Abstract

Objective: Pre-hospital, in-hospital, and patient factors are associated with variation in door to needle (DTN) time in acute ischemic stroke (AIS). Publications are usually from large single centers or multicenter registries with less reporting on national results.Materials and methods: All AIS patients treated with intravenous tissue plasminogen activator (iv-tPA) over 4 years (2013–2016) in Northern Ireland were recorded prospectively, including patient demographics, pre-hospital care, thrombolysis rate, and DTN time. Logistic regression was performed to identify factors associated with DTN time.Results: One thousand two hundred and one patients from 10,556 stroke admissions (11.4%) were treated with iv-tPA. Median NIHSS was 10 (IQR 6-17). Median DTN time was 54 min (IQR 36-77) with 61% treated < 60 min from arrival at hospital. National thrombolysis numbers increased over time with improving DTN time (P = 0.002). Arrival method at hospital (ambulance OR 2.3 CI1.4-3.8) pre-alert from ambulance (pre-alert OR = 5.3 CI3.5-8.1) and time of day (out of hours, n = 650, OR 0.20 CI 0.22-0.38) all P < 0.001, were the independent factors in determining DTN time. Variation in DTN time between centers occurred but was unrelated to volume of stroke admissions.Conclusion: Ambulance transport with pre-hospital notification and time of day are associated with shorter DTN time on a national level. Most thrombolysis was delivered outside of normal working hours but these patients are more likely to experience treatment delays. Re-organization of stroke services at a whole system level with emphasis on pre-hospital care and design of stroke teams are required to improve quality and equitable care in AIS nationally.

Highlights

  • Reperfusion with intravenous tissue plasminogen activator and/or endovascular thrombectomy improves probability of better outcome following acute ischemic stroke (AIS) [1, 2]

  • There were 10,556 AIS admissions resulting in an overall thrombolysis rate of 11.4% for the 4 year period (Table 1)

  • The mean age of AIS patients treated with iv-tPA was 72 (SD 14) years

Read more

Summary

Introduction

Reperfusion with intravenous tissue plasminogen activator (ivtPA) and/or endovascular thrombectomy improves probability of better outcome following acute ischemic stroke (AIS) [1, 2]. Patient and systemic factors mean that only a proportion of AIS patients receive thrombolytic treatment [3, 4]. The impact of reperfusion is time dependent [5]. Guidelines encourage ivtPA treatment within a 60 min door-to-needle (DTN) time after hospital arrival [6, 7]. Some centers report dramatic reductions in DTN time after service re-organization [8]. Improvement in DTN times have been more variable despite dedicated improvement programs [9]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.